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Prader-Willi syndrome (PWS) is a neurodevelopmental disorder that is characterized by 
rapid eye movement (REM) sleep abnormalities. The disease is caused by genomic 
imprinting defects that are inherited through the paternal line. Among the genes located 
in the PWS region on chromosome 15 (15q11-q13), small nucleolar RNA 116 
(Snord116) has been previously associated with intrusions of REM sleep into 
wakefulness in both humans and mice. 
Here, we further explore the processes of sleep regulation by studying the PWScrm+/p- 
mouse line, which carries a paternal deletion of Snord116. We focused on 
microstructural electrophysiological components of sleep, such as REM sleep features 
and sleep spindles within NREM sleep. While the former are thought to contribute to 
neuronal network formation early in brain development, the latter are markers of 
thalamocortical processes. Both signals are often compromised in neurodevelopmental 
disorders and influence functional properties of cortical neurons. Thus, we isolated and 
characterized the intrinsic activity of cortical neurons using in vitro microelectrode array 
(MEA) studies. 
Our results indicate that the Snord116 gene in mice selectively influences REM sleep 
properties, such as theta rhythms and the organization of REM episodes throughout 
sleep-wake cycles. Moreover, sleep spindles present specific abnormalities in PWS 
model systems, indicating that these features of sleep may translate as potential 
biomarkers in human PWS. We observed abnormalities in the synchronization of cortical 
neuronal activity that are accounted for by high levels of norepinephrine. 
In conclusion, our results provide support for an important role of Snord116 in regulating 
brain activity during sleep and, in particular, cortical neuronal properties, thereby opening 
new avenues for developing interventions in PWS. 
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We found that the Snord116 gene, a major player in Prader-Willi syndrome (PWS), 
significantly impacts REM sleep and its regulation. Additionally, we found that sleep 
spindles, a subtle electroencephalography (EEG) marker that occurs during NREM 
sleep, are dysregulated in PWS mice that carry a paternal deletion of the Snord116 
gene. Using a combination of in vivo and in vitro experiments, we identified sleep 
features at the network and molecular level that suggest that Snord116 is fundamental in 
the synchronization of neuronal networks. Our study also provides a new pre-clinical tool 
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Sleep and circadian alterations are frequently reported in subjects with Prader-Willi 
syndrome (PWS), representing a burden that impacts the quality of life for patients and 
their families. Indeed, up to 76% of PWS patients exhibit abnormal sleep (Gunay-Aygun, 
Schwartz, Heeger, O'Riordan, & Cassidy, 2001; Williams, Scheimann, Sutton, Hayslett, 
& Glaze, 2008). PWS is a neurodevelopmental disorder characterized by hypotonia and 
failure to thrive in infancy. From approximately 2 years of age, the phenotype shifts to 
hyperphagia, which leads to obesity (Holland, Treasure, Coskeran, & Dallow, 1995; 
Tauber, Thuilleaux, & Bieth, 2015). Other phenotypic hallmarks of PWS include mild to 
moderate cognitive deficits, behavioural problems including obsessive–compulsive 
disorder, and sleep disturbances. Among these sleep disturbances, PWS subjects 
exhibit excessive daytime sleepiness (EDS) (Camfferman, McEvoy, O'Donoghue, & 
Lushington, 2008; Helbing-Zwanenburg, Kamphuisen, & Mourtazaev, 1993) and rapid 
eye movement (REM) sleep dysregulation (Bruni, Verrillo, Novelli, & Ferri, 2010; Vela-
Bueno et al., 1984; Vgontzas et al., 1996). Such REM dysregulation implies a disruption 
in the circadian rhythms, producing an irregular sleep-wake cycle, and may be linked to 
the abnormal thermoregulation observed in PWS subjects (Clarke, Waters, & Corbett, 
1989). Some studies have also reported narcoleptic-like symptoms such as sleep 
attacks, cataplexy and a transient loss of muscle tone (Tobias, Tolmie, & Stephenson, 
2002; Vgontzas et al., 1996). 
PWS is caused by the lack of expression of paternally imprinted genes in the 
chromosomal region 15q11-q13 The small nucleolar RNA (snoRNA) clusters in this 
region have a pivotal role in the aetiology of the disease. Individuals lacking the 
SNORD116 snoRNA cluster and the IPW (imprinted In Prader-Willi Syndrome) gene 
suffer the same failure to thrive, hypotonia, and hyperphagia that are observed in 
subjects with larger deletions and maternal uniparental disomy (de Smith et al., 2009; 
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Sahoo et al., 2008). Additionally, it has been shown that mice with a paternal deletion of 
the Snord116 gene (PWScrm+/p-) recapitulate the major human endophenotypes, 
including sleep alteration coupled with dysregulation of diurnal clock genes (Lassi et al., 
2016; Powell & LaSalle, 2015). 
We have previously described sleep alterations in PWScrm+/p- mice, mostly related to 
REM sleep (Lassi et al., 2016). Here, we explored a specific feature of sleep 
microstructure concerning the processes that regulate REM sleep in PWScrm+/p- mice. 
Next, we investigated sleep spindles, hallmarks of NREM sleep that have traditionally 
been challenging to characterize in mouse studies. Spindle activity is attributed to 
interactions between thalamic reticular, thalamocortical, and cortical pyramidal networks 
(Steriade, McCormick, & Sejnowski, 1993). Dysregulation of spindle properties is a 
sensitive indicator of thalamocortical and neuromodulator dysfunction in many diseases, 
including neurodevelopmental disorders (Krol, Wimmer, Halassa, & Feng, 2018). 
Previous studies have reported a complete absence or dysregulation of sleep spindles in 
PWS subjects (Gilboa & Gross-Tsur, 2013; Hertz, Cataletto, Feinsilver, & Angulo, 1993). 
Since children with PWS have been shown to have abnormal functional connectivity 
among brain regions (Zhang et al., 2013), a phenomenon that can derive from cortical 
and/or subcortical structures, these alterations may be responsible for the sleep 
alterations observed in PWS. Therefore, we sought to investigate the regulation of sleep 
by analysing electrophysiological elements dependent on the thalamocortical projections 
and intrinsic cortical processes. To investigate the properties of intrinsic cortical 
connectivity, with no interference from external stimuli and from the thalamocortical 
projections (Hinard et al., 2012), we studied in vitro cultures of dissociated cortical 
neurons using microelectrode array (MEA) recordings. 
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Our results confirm the function of the Snord116 gene in sleep regulation and extend our 
understanding of sleep in PWS, for the first time, to the microstructure of sleep, a fine 
regulatory cortical process that controls sleep architecture. 
Materials and Methods 
In vivo study 
Animals 
Animal procedures were performed at the Istituto Italiano di Tecnologia (IIT) Genova and 
were approved by the Animal Research Committee and the Veterinary Office of Italy. All 
efforts were made to minimize the number of animals used, as well as any pain and 
discomfort, according to the principles of the 3 Rs (replacement, reduction, and 
refinement) (Tornqvist et al., 2014). 
Mice carrying a paternal deletion of the Snord116 gene and IPW exons A1/A2 B 
(Skryabin et al., 2007) (PWScrm+/p-) were used in this study, along with wild-type mice 
(PWScrm+/p+). In order to maintain the colony, patrilineal descendants of the original 
transgenic mice were bred on a C57BL/6J background. For the genotyping protocol, see 
the supplementary methods. 
All animals used in this study were housed under controlled temperature conditions (22 ± 
1 °C as room temperature) on a 12 h:12 h light/dark cycle (lights on 07:00–19:00). Food 
(standard chow diet) and water were provided ad libitum. 
 
Experimental design 
For the study, male mice with paternally inherited Snord116 deletions (PWScrm+/p-) and 
wild-type littermate control mice (PWScrm+/p+) aged 15 to 18 weeks were used. 
To investigate the impact of Snord116 in the sleep architecture, we made continuous 
recordings by electroencephalography combined with electromyography (EEG/EMG) for 
24 h (12 h:12 h light/dark cycle, Figure 1A). Subsequently, we investigated changes in 
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spindle properties at specific time points across the sleep-wake cycle. Specifically, 
EEG/EMG recordings were made for 2 h at two different time points as the baseline 
condition (B1 and B2; Figure 1D) to investigate spindle properties related to (i) circadian 
variation (switch from light to dark periods) and (ii) homeostatic variation (low and high 
sleep pressure). Thus, we investigated the frequency of sleep spindles and their 
properties in response to perturbation of sleep by performing 6 h of total sleep 
deprivation (SD). EEG/EMG recordings were made over the first hour of the rebound 
period (RB, Figure 1D) following 6 h of SD (RB1) and at two other time points over the 
18 h recovery period (RB2 and RB3, Figure 1D). 
In vivo SD protocol 
Total SD was performed by gentle handling techniques, consisting of introducing novel 
objects into the cage or agitating (knocking or shaking) the cage when behavioural signs 
of sleep were observed. Animals were subjected to SD during the first 6 h of the light 
period, when mice usually sleep and are under high sleep pressure. 
 
EEG/EMG electrode implantation. 
A total of 28 mice were used for the in vivo sleep study (n=14 PWScrm+/p- and n=14 
PWScrm+/p+ mice). Each mouse was anaesthetized using 1.5%–2.5% isoflurane in 
oxygen and surgically implanted with a telemetric transmitter (volume, 1.9 cm 3; total 
weight, 3.9 g; TL11M2-F20-EET; DSI, St. Paul, MN, USA) connected to electrodes for 
continuous EEG/EMG recording to assess the sleep-wake cycle. A wireless EEG 
transmitter/receiver was subcutaneously implanted. EEG wire electrodes were implanted 
epidurally over the right frontal cortex (coordinates: 2 mm posterior to bregma and 2 mm 
lateral to the midline, in the right frontal part of the skull) and the right parietal cortex 
(coordinates: 3 mm anterior to lambda and 2 mm lateral to the midline, in the right 
parietal part of the skull). EMG was recorded with 2 stainless steel wires inserted 
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bilaterally into the neck muscles ~5 mm apart and sutured in place (Figure 1A). 
Following surgery, all animals received paracetamol (200 mg/kg by mouth once a day; 
Tempra) and enrofloxacin (10 mg/kg subcutaneously once a day; Baytril) for two days 
after surgery. The animals were housed individually in their home cages for a recovery 




Cortical EEG and EMG signals were recorded using Dataquest A.R.T. (Data Science 
International). Activity data measured only relative movement, which is dependent on the 
orientation and distance between the transmitter and receiver. Signals were digitized at a 
sampling rate of 500 Hz with a filter cut-off of 50 Hz. EEG signals were filtered at 0.3 Hz 
(low-pass filter) and 0.1 kHz (high-pass filter), respectively. The polysomnographic 
recordings were visually scored offline using SleepSign software (Kissei Comtec Co. Ltd, 
Japan) in four-second epochs to identify the wakefulness (W), NREM sleep (NR) or REM 
sleep (R) stages as previously described (Pace, Adamantidis, Facchin, & Bassetti, 2017; 
Pace et al., 2018). Scoring was performed by a single observer who was blinded to the 
group assignments of the mice. EEG epochs determined to have artefacts (interference 
caused by scratching, movement, eating, or drinking) were excluded from the analysis. 
Artefacts comprised <5-8% of all recordings used for analysis. 
The numbers of epochs spent in wakefulness, NREM and REM were determined for a 
24 h circadian period, across the light and dark phases (L:D = 12:12). The amount of 
time spent in each stage was established by the count of the epoch type (W, NR, or R) 
and averaged over 2-h periods. The spectral characteristics of the EEG data were further 
analysed. EEG power density for delta (0.5–4 Hz) frequencies in NREM sleep was 
computed over the 24 h of recording time. The power of each 0.5 Hz bin was first 
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averaged across the sleep stages individually and then normalized by calculating the 
relative duration of each bin from the total power (0–20 Hz) for each individual animal. 
A two-way repeated-measures ANOVA with factors of group x time was used for the 
statistical analysis of two-hour averaged time-course changes in the quantity of each 
sleep stage (W, NREM and REM) and for physical activity. The statistical analysis of the 
cumulative amounts of W, NREM, and REM over the dark and light periods between 
genotypes was carried out with a two-tailed t-test. A two-way repeated-measures 
ANOVA with factors of group x frequency (Hz) was used for the statistical analysis of 
EEG power for NREM sleep over the 24 h recording period. 
 
REM sleep characterization 
Additional analyses were performed to characterize the REM sleep alterations observed 
in the PWScrm+/p- mice. In particular, a more detailed analysis of REM sleep was carried 
out according to the partition of REM sleep episodes into single and sequential episodes, 
which has originally been proposed for rats (Zamboni, Amici, Perez, Jones, & 
Parmeggiani, 2001). First, the REM sleep intervals (RSIs), given by the sum of the time 
spent in wakefulness and in NREM sleep between two REM sleep episodes, were 
calculated. Here, the bimodal distribution of RSI length was determined using a kernel 
density estimation mathematical model, and single REM sleep episodes and sequential 
REM sleep episodes were discriminated (Figure S1). A single RSI is defined as one that 
is both preceded and followed by long RSIs >60 sec each, while sequential REM sleep 
episodes are those that are separated by short RSIs ≤ 60 sec each (Figure 1C). 
Second, the REM-NREM cycle, which is defined as the interval between the onset of 
consecutive REM episodes, was assessed. The following criteria were used: 8 sec was 
the minimum length of a REM sleep episode; and cycles that were longer than 30 
minutes were excluded from the analysis, since it has been already documented in 
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mouse studies that the cycle length is approximately 2-5 minutes (Toth & Bhargava, 
2013). An unpaired t-test was used to assess differences between short and long RSIs 
and differences in the number of REM-NREM sleep cycles. 
 
Sleep spindle properties 
Individual sleep spindles were detected using a wavelet-based spindle detection method 
(Bandarabadi, 2018). Briefly, the algorithm estimates the energy of EEG signal within 9-
16 Hz range using the continuous wavelet transform, and then applies a threshold (3 SD 
+ Mean) to detect candidate spindles. A lower threshold (1 SD + Mean) is then applied to 
find start and end points of the candidate spindles. Detected events that meet these 
criteria are considered as spindles; (i) duration between 0.4-2 s, (ii) number of cycles 
between 5-30, (ii) increase in power should be specific to the spindle range. Afterward, 
several properties of the detected spindles are calculated automatically, such as density, 
duration, central frequency, peak-to-peak amplitude, and symmetry. 
 
Neurochemical analysis 
Neurochemical analysis was performed in PWScrm+/p- mice (n = 5) and PWScrm+/p+ mice 
(n = 5). Mice were anaesthetized with isoflurane at the beginning of the dark period to 
collect cerebrospinal fluid (CSF). We decided to collect samples at this time point 
because REM sleep alterations were observed at this stage. CSF was sampled as 
previously described (Liu & Duff, 2008). Mice were anaesthetized using 1.5%–2.5% 
isoflurane in oxygen and placed on a platform, and the arachnoid membrane covering 
the cisterna magna was punctured. The positive flow pressure allows the collection of 
CSF using a glass micropipette with a narrow tip. Three to eight microliters of CSF per 
mouse was collected and stored at −80 °C in polypropylene tubes. 
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CSF preparation for ultrahigh-performance liquid chromatography-tandem mass 
spectrometry (UPLC-MS/MS) 
Eighteen microliters of a solution containing 1 µM each of Glu-d5 and GABA-d6 and 50 
nM His-d4 in aqueous 0.1% formic acid was added to 2 µL of each thawed sample of 
CSF and then vortexed and centrifuged for 10 minutes at 14,000 rpm. The resulting 
supernatants were moved to glass vials for injection. Calibration standards were 
prepared by spiking artificial CSF (150 mM Na, 3 mM K, 1.4 mM Ca, 0.8 mM Mg, 1 mM 
P, 155 mM Cl, 10 mM glucose, 0.5 mg/mL albumin) with stock standard solutions. These 
calibrators were further diluted 1:10 with the internal standard solution, vortexed and 
centrifuged before injection. 
 
UPLC-MS/MS 
Chromatographic separation was performed with an Acquity UPLC system (Waters, 
Milford, MA, USA) using an ACE C18-Ar column (2 µm particle size, 2.1x150 mm 
(purchased from Advanced Chromatography Technologies Ltd, Aberdeen, Scotland, 
UK). Separation was carried out at a flow rate of 0.5 mL/min. The eluents were as 
follows: A, aqueous 0.1% formic acid with 5 mM n-perfluoropentanoic acid (NFPA); B, 
acetonitrile with 0.1% formic acid. The gradient used starts with 1 minute at 1% B, 
increasing linearly from 1% to 50% B in 2.5 minutes, and then remaining at 50% B for 30 
sec before the column was equilibrated with the initial conditions for 2 additional minutes, 
adding up to a run time of 6 minutes. The column and autosampler temperatures were 
set to 45 and 10 °C, respectively. The injection volume was set to 4 µL. Analysis was 
performed on a XEVO TQ-S triple quadrupole mass spectrometer (Waters) equipped 
with an electrospray source operated in positive mode. Nitrogen was used as the 
desolvation (800 L/h, 450 °C) and collision gas. Data were acquired in the multiple 
reaction monitoring (MRM) mode, with the settings of the precursors, fragments, cone 
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voltages and collision energies for each compound as indicated in Supplementary Table 
1. Waters MassLynx 4.1 and TargetLynx 4.1 software were used for data acquisition and 
processing, respectively. A paired t-test was used to compare the levels of each 
neurotransmitter between the two genotypes. 
 
In vitro study 
Cell culture 
Cortical cultures prepared from embryonic mice at gestational day 18 were plated on 60-
channel MEAs (Multi Channel Systems, MCS, Reutlingen, Germany) that had been 
coated with borate buffer and poly-L-lysine to promote cell adhesion (final density 
approximately 1200 cells/mm2). We recorded the activity of neuronal networks at 19 ± 1 
days in vitro (DIV; mean ± SD), as already described (I. Colombi, F. Tinarelli, V. 
Pasquale, V. Tucci, & M. Chiappalone, 2016), in mice carrying a paternal deletion of the 
Snord116 gene (PWScrm+/p-) (Skryabin et al., 2007) and in wild-type mice (PWScrm+/p+). 
 
Experimental protocol 
We recorded the spontaneous activity in 9 cultures from PWScrm+/p- mice and 6 from 
PWScrm+/p+ mice for 2 h in culture solution as the baseline (BL) condition. Then, cells 
were recorded continuously for 2 hr following the administration of Carbachol (CCh, 
Sigma-Aldrich, 20 µM). 
 
MEA recordings 
Planar microelectrodes were arranged in an 8×8 layout, excluding corners and one 
reference electrode, for a total of 59 round planar TiN/SiN recording electrodes (30 µm 
diameter; 200 µm centre-to-centre inter-electrode distance). The activity of all cultures 
was recorded by means of the MEA60 System (MCS). The signal from each channel 
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was sampled at 10 kHz and amplified using an MCS amplifier with a frequency band of 1 
Hz-3 kHz. Each recorded channel was acquired through the data acquisition card and 
monitored online through MC_Rack software (MCS). In order to reduce thermal stress on 
the cells during the experiment, the MEAs were kept at 37 °C by means of a controlled 
thermostat (MCS) and covered with polydimethylsiloxane (PDMS) caps to prevent 
evaporation and changes in osmolality. 
 
Data analysis and statistics 
Starting from the raw data (i.e., the wide-band signal), we used a dual process to 
analyse both MUA (multiunit activity, f>300 Hz) and LFPs (local field potentials, f<300 
Hz). To capture only MUA activity, we high-pass-filtered the raw signal. When spikes 
(i.e., single over-threshold peaks) and bursts (i.e., groups of tightly packed spikes) were 
detected in the MUA recordings, we computed the following parameters for each 
channel: mean firing rate (MFR, spikes/sec), mean bursting rate (bursts/min), inverse 
burst ratio (IBR, percentage of spikes outside the burst), burstiness index (BI, an index of 
the burstiness level of the network), burst duration (BD, msec), mean frequency 
intraburst (MFB, spikes/sec), interburst interval (IBI, msec) and spike time tiling 
coefficient (STTC). Finally, we computed the cross-correlation between each pair of 
burst trains recorded from active channels (i.e., with MFR>0.05 spikes/sec). For each 
channel, we considered only the first spike for each burst (i.e., the burst event), and we 
computed the cross-correlation function that represents the probability of observing a 
burst in one channel i at time t+τ (τ=3 msec) given that there is a burst in a second 
channel i+1 at time t. To quantify the strength of the correlation between each pair of 
electrodes, we evaluated the correlation peak (Cpeak). We selected only the first 100 Cpeak 
values to identify only the most significant correlations. Finally, we analysed the latency 
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from the peak (Lpeak) and considered the corresponding peak latency values of the 
preselected 100 strongest Cpeak values (El Merhie et al., 2018). 
To select the LFP components, we low-pass-filtered the raw data between 1 and 300 Hz. 
We then computed the power spectral density of the decimated signal (sampling 
frequency 1 kHz) (μV²/Hz) using the Welch method (windows=5 sec, overlap=50%). We 
considered only the lower-frequency bands of the signal; these bands, particularly the 
delta (0.5-4 Hz), theta (4-11 Hz), and beta (11-30 Hz) bands (I. Colombi et al., 2016), are 
of particular interest in the study of the sleep-wake cycle. To characterize the LFP, we 
calculated the power in each of those frequency bands. 
 
Measurement of in vitro and in vivo gene expression by real-time quantitative PCR 
Total RNA was extracted from mouse cortices and from cortical cultures to assess the 
changes in distinct classes of genes that have already been shown to be differentially 
expressed during sleep and wakefulness (Cirelli, Faraguna, & Tononi, 2006; Cirelli & 
Tononi, 2000a, 2000b; Hinard et al., 2012). These genes are immediate early genes and 
clock genes (Cfos; Arc; Homer1a, Dpb, Bmal1 and Per2). The Bdnf gene, which is 
involved in neuroplasticity and responds rapidly to SD (Schmitt, Holsboer-Trachsler, & 
Eckert, 2016), was also investigated. RNA was extracted from the cortex of 10 male 
PWScrm+/p- mice (n= 5) and PWScrm+/p+ mice (n= 5). Mice were sacrificed by cervical 
dislocation at two different time points: (i) 6 h after the onset of the light period as a 
baseline value (ZT6), before which the mice were kept undisturbed in their home cages 
and (ii) 1 h after 6 h of total SD. The latter time point was used because in the in vitro 
experiments, gene expression analysis was performed 1 h after CCh treatment. The 
effect of CCh resembles that of SD. Total RNA was isolated separately from the frontal 
cortex (FC) and parietal cortex (PC) with TRIzol (Life Technologies) according to the 
manufacturer’s instructions (Chomczynski & Mackey, 1995). Primary cortical neurons 
.CC-BY-NC-ND 4.0 International licensea
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under 





were treated at DIV 20 with 20 μM CCh for 1 h. Then, neurons were washed three times 
with ice-cold phosphate-buffered saline solution and lysed with 300 μl of TRIzol. All RNA 
concentrations were then determined by a NanoDrop 2000c spectrophotometer. 
Complementary DNA was reverse transcribed from up to 2 mg of total RNA using a high-
capacity RNA-to-cDNA kit (Invitrogen) and then analysed with SYBR GREEN qPCR mix. 
Reactions were performed in three technical replicates using an AB 7900HT fast real-
time PCR system (Applied Biosystems). The relative quantification of expression levels 
was performed using a previously described ΔΔCT calculation method (Pace et al., 
2017). Gapdh was used as a reference gene. The specific primer pairs used for the 
analysis were designed using Primer3 (Supplementary Table 2). An unpaired t-test was 
used to compare differences between the genes investigated in the two genotypes. 
 
Statistical analysis 
The normality of the distribution of values was tested with the Kolmogorov–Smirnov test. 
Data are presented as the mean ± standard error of the mean (SEM). As detailed above 
for the in vivo experiment, most data were analysed using two-way ANOVA and 
Student’s t-test as appropriate for the experimental design. If the P values reached 
statistical significance, Bonferroni adjustment was further applied for post hoc analysis. 
For the sleep analysis, Phenopy was used (Balzani, Falappa, Balci, & Tucci, 2018), while 
GraphPad Prism6 (GraphPad Prism Software, Inc.) was used for statistical analysis. 
Type I error (α) was set at 0.05 (p < 0.05). 
For MEA recordings, belonging to the in vitro experiment, data were analysed using two-
way repeated-measures ANOVA (factors=genotype x treatment) followed by Tukey’s 
post hoc test. SigmaPlot software (Systat Software Inc.) was used for statistical analysis 
to compare data from two different populations, we performed the Mann-Whitney test, 
since data were not normally distributed. 
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Paternal Snord116 deletion impacts the microstructure of sleep in mice 
To assess whether Snord116 might contribute to sleep disturbances associated with 
PWS, we recorded the sleep-wake cycle over the 24 h circadian period (12 h:12 h 
light/dark cycle) of PWScrm+/p- and PWScrm+/p+ mice (Figure 1A). Both genotypes 
exhibited the typical circadian change in the sleep-wake distribution, with reduced sleep 
(NREM and REM sleep) during the dark hours compared to the light hours (Figure S2A). 
Total sleep and wake duration showed no obvious differences between the two cohorts 
of mice (Figure S2A). In contrast, the total amount of REM sleep was increased in mice 
lacking a paternal Snord116 gene during the dark period (PWScrm+/p+ 2.425 ± 0.5083 vs 
PWScrm+/p+ 3.865 ± 0.4334, t(18)= 2.15, p=0.04; Figure 1B). Next, we assessed the EEG 
power spectra, and  
Delta (4 – 4.5 Hz) power density during NREM sleep was found to be significantly 
reduced in the PWScrm+/p- mice compared to the control mice (two-way ANOVA: F (39, 
351) = 44.13 p<0.0001; “Frequency Hz”, Figure S2B). 
Since the EEG analysis highlighted an alteration of REM sleep, which reflects a change 
in the distribution of REM periods with no effects on total sleep or wakefulness, we 
further explored the duration of REM sleep episodes in detail. Our results show, for the 
first time, the presence of a bimodal distribution of RSI in mice. RSI was bimodally 
distributed in both genotypes of mice over the 24 h circadian period, with the two clusters 
separated at 55 sec, which accounts for the minimum frequency (Figure 1C). Based on 
these parameters, the two subpopulations of RSI detected were used to distinguish 
single REM sleep episodes (long RSI >60 sec) and sequential REM sleep episodes 
(short RSI ≤60 sec). Although a bimodal distribution was observed in both genotypes of 
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mice, the frequency of short RSIs was significantly higher in the PWScrm+/p- mice than in 
the PWScrm+/p+ mice (PWScrm+/p+ 3.40 ± 0.99 vs PWScrm+/p+ 7.6 ± 1.6, t(18)= 2.21, 
p=0.03; Figure 1C), suggesting a high REM sleep propensity in the mutant mice. 
Conversely, the numbers of long RSIs were unchanged between the two genotypes 
(Figure 1C). In addition, the REM-NREM cycle was analysed as an identifier of sleep 
propensity (Trachsel, Tobler, Achermann, & Borbely, 1991). Our data showed that the 
cycle length was approximately 2-5 minutes in both genotypes of mice, as already 
described (Toth & Bhargava, 2013). However, in the PWScrm+/p- mice, a large increase in 
REM-NREM cycles was observed over the 24 h of the sleep-wake cycle (PWScrm+/p+ 
9.00 ± 2.06 vs PWScrm+/p+ 15.15 ± 1.51, t(18)= 2.40, p=0.02; Figure 1C). 
 
Paternal deletion of Snord116 alters sleep spindles in PWS mice 
Sleep spindle properties were explored in relation to the circadian and homeostatic 
components of sleep (Figure 1D). Sleep spindles are the best-characterized source of 
EEG power in the 9–16 Hz range during NREM sleep (see Figure 1E). We calculated 
these spindle properties for each genotype at different time points and found that the 
density of spindles was unchanged between the two genotypes in all conditions 
investigated (Figure 1E). However, we observed that spindle duration (t(1988)= 3.04, 
p=0.002; Figure 1E), central frequency (t(1988)= 2.70, p=0.006; Figure 1E), and the 
number of spindle cycles (t(1988)= 3.47, p=0.005; Figure 1E) were significantly 
increased in the PWScrm+/p- mutants compared to the control mice. Conversely, spindle 
amplitude was significantly lower in the PWScrm+/p- mutants compared to the PWScrm+/p- 
mice (t(1988)= 18.59, p<0.0001; Figure 1E). 
 
PWS mutants show increased spontaneous physical activity over the circadian 
cycle 
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Physical activity was assessed in awake mice without any motor constraints. During the 
24 hours of the circadian period, both genotypes showed an increase in physical activity 
during the night and a decrease in motility during the day. Interestingly, mutant mice 
displayed an increase in spontaneous physical activity during the subjective night (light 
phase, resting phase for mice) compared to control mice (PWScrm+/p+ 2.48 ± 0.44 vs 
PWScrm+/p+ 3.96 ± 0.33, t(18)= 2.6, p=0.01; Figure 2A). Moreover, physical activity was 
also increased in the mutant mice during the first hours of the dark period compared to 
the motor activity of control mice (two-way ANOVA: F(11,99) = 9.318, p<0.0001, “time of 
day”, and F(1,9) = 5.23, p=0.04, “groups”; Figure 2A). 
 
Paternal Snord116 deletion leads to dysregulation of norepinephrine 
Neuromodulators are fundamental players in the regulation of sleep-wake cycles. Here, 
we report an assessment of the levels of glycine, glutamate, norepinephrine, histamine 
and GABA in the CSF of both genotypes. Notably, among all the investigated 
neuropeptides, it was found that the levels of norepinephrine, a neurotransmitter that is 
involved in arousal and is also important for the regulation of REM sleep (Mallick et al., 
2002; Mitchell & Weinshenker, 2010), was significantly increased in the PWScrm+/p- mice 
relative to the control (PWScrm+/p+ 0.53 ± 0.07 vs PWScrm+/p+ 0.08 ± 0.01, t(8)= 6.22, 
p=0.0003; Figure 2B). 
 
REM-like in vitro phenotypes emerge from paternal Snord116 deletion neurons 
To assess whether Snord116 impacts the communication of cortical networks of neurons 
isolated from the thalamocortical connections, we studied electrophysiological and 
transcriptional changes in dissociated embryonic cortical neurons obtained from 
PWScrm+/p- and PWScrm+/p+ mice. We administered CCh to the cultures to suppress the 
delta wave activity and emphasize activity in the theta frequency range. We recorded two 
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hours of baseline neuronal activity (i.e., basal phase) in the culture medium, followed by 
two hours of CCh administration for both genotypes (PWScrm+/p- and PWScrm+/p+ 
cultures). We compared the electrophysiological activity on two different time scales: 
LFP and MUA. 
First, we analysed the low-frequency component of the signal to investigate whether 
PWScrm+/p- cultures showed an alteration in the theta oscillations during CCh 
administration. Our results, in agreement with our previous studies, demonstrated 
dysregulation of the electrophysiological activity in the theta frequency band of 
PWScrm+/p- mice during REM sleep (Lassi et al., 2016) over the 24 h circadian period (as 
the baseline condition). In the baseline condition, cortical networks from both genotypes 
revealed spontaneous synchronized bursting resembling the slow-wave activity typical of 
NREM sleep. Indeed, the analysis of the LFP performed in PWScrm+/p- and PWScrm+/p+ 
cultures during spontaneous phase did not indicate differences between the genotypes 
(Figure S3). 
We then stimulated cortical cultures with CCh as previously described (I. Colombi et al., 
2016) (Figure 3B) and we normalized power with respect to the basal condition. 
Following CCh administration, the power of the delta waves decreased by 80% in both 
sets of cultures (Figure 3C). We found a significant difference between the two sets of 
cultures (i.e., PWScrm+/p- and PWScrm+/p+) only in the theta waves after 1 h of CCh 
application (time point=30′: q= 3.222; p=0.029; time point=60′: q=3.828; p=0.011; time 
point=90′: q= 3.94; p=0.009; time point=120′: q= 3.693; p=0.013) (Figure 3C1). 
Specifically, the theta power of the control cultures decreased by 60%. In contrast, the 
theta power of the PWS cultures decreased by 30%. These results are consistent with 
the results of the in vivo experiment that revealed abnormalities in REM sleep 
characterized by theta waves. Beta waves did not show significant differences between 
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the two genotypes. Detailed statistical information about the multiple comparisons is 
available in Table S3. 
 
Paternal Snord116 deletion alters the synchronization of activity and delays 
response to CCh treatment 
Subsequently, we analysed the high frequency range of the signal to evaluate possible 
network activity defects correlated with the syndrome. First, we compared the first two 
hours of the spontaneous activity highlighted in Figure 4A. PWScrm+/p+ revealed highly 
synchronized activity during the basal phase, composed of network-wide bursts 
separated by periods of nearly complete quiescence, or asynchronous action potentials 
(Chiappalone, Vato, Berdondini, Koudelka-Hep, & Martinoia, 2007; Eytan & Marom, 
2006; van Pelt, Wolters, Corner, Rutten, & Ramakers, 2004), as depicted in the raster 
plot of one representative experiment Figure 4B. In contrast, PWScrm+/p- cultures 
displayed a relatively asynchronous firing pattern, as demonstrated by the following 
analysis. We found no significant differences by comparing the firing rate during 
baseline, denoting a comparable starting level of activity (Figure 4C light blue box and 
light red box for PWScrm+/p+ and PWScrm+/p- cultures, respectively). PWScrm+/p- cultures 
displayed more desynchronized activity than PWScrm+/p+ resulted in a reduced BI (Mann-
Whitney U test; Z=2.18, p=0.02) (BI, Figure 4C1) and STTC (Mann-Whitney test; Z=2.29, 
p=0.01; Figure 4C2). The analysis of the cross-correlation of burst events (Figure 4C3-
C4) revealed a statistically significant difference in the latency of the top 100 connections 
between the two groups under basal conditions (Mann-Whitney test; Z= -1.94; p=0.049) 
(Figure 4 C4). We did not find any significant difference in the Cpeak values (Figure 4C3). 
To enable the behaviour of the cultures to be compared during CCh stimulation, we 
normalized the results of each experiment to the mean values obtained during basal 
recording. In the PWScrm+/p+ cultures (Figure 4F, blue line), the activity level evaluated by 
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means of the MFR increased after CCh administration compared to the basal condition, 
but we did not find any significant difference. At the same time, CCh application resulted 
in an increased number of isolated spikes (i.e., an increased IBR value, Figure 4 F1) 
(two-way repeated-measures ANOVA; basal phase vs CCh 30′: q= 5.87, p=0.001; basal 
phase vs CCh 60′: q=6.62, p<0.001; basal phase vs CCh 90′: q=7.02, p<0.001; basal 
phase vs CCh 120′ q=5.639, p=0.002) and a decrease in the BI (two-way repeated-
measures ANOVA; basal phase vs CCh 30′: q=4.338; p=0.02; basal phase vs CCh 60′: 
q= 6.21 p<0.001; basal phase vs CCh 90′: q= 6.603, p<0.001; basal phase vs CCh 120′: 
q= 6.95 p<0.001) (Figure 4F2) and STTC (two-way repeated-measures ANOVA; basal 
phase vs CCh 30′: q= 5.181, p=0.005; basal phase vs CCh 60′: q= 7.069, p<0.001; basal 
phase vs CCh 90′: q= 6.666 p<0.001; basal phase vs CCh 120′: q= 6.125 p<0.001) 
(Figure 4F3) compared to the basal phase, indicating a loss of bursting activity and of 
synchronicity. Moreover, CCh causes a fragmentation of burst structures resulting from 
an increase in BD (Figure 4 F4) (two-way repeated measure ANOVA; basal phase vs 
CCh 60′: q= 5.142, p=0.006; basal phase vs CCh 90′: q= 6.02, p<0.001; basal phase vs 
CCh 120′: q= 6.504, p<0.001), a decrease in the peak of cross-correlation on burst 
events (Cpeak, Figure 4F5) (two-way repeated measure ANOVA; basal phase vs CCh 30′: 
q= 4.474, p=0.021; basal phase vs CCh 60′: q= 5.805, p=0.001; basal phase vs CCh 90′: 
5.938 p=0.001; basal phase vs CCh 120′: q= 5.58, p=0.002) and an increase in the 
latency of the top 100 connections (Lat, Figure 4F6) (two-way repeated measure 
ANOVA; basal phase vs CCh 60′: q= 4.962, p=0.008; basal phase vs CCh 90′: 4.263 
p=0.031). Indeed, the relative changes of the analysed parameters upon CCh 
administration in PWScrm+/p+ cultures are consistent with the previous results obtained in 
cortical cultures from embryonic rats despite the different in vitro ages (DIVs) of cultures 
recorded (I. Colombi et al., 2016). Although the starting level of spontaneous firing was 
comparable between genotypes (Figure 4C), CCh had a delayed effect in PWScrm+/p- 
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cultures. We found a significant difference between the first 30 minutes and the last one 
hour of CCh administration for the MFR ratio (two-way repeated-measures ANOVA; CCh 
30′ vs CCh 120′: q= 4.783, p=0.012) (Figure 4 F). We did not find any significant 
difference in the IBR ratio of PWScrm+/p- at any time point of 30 minutes (Figure 4F1). In 
contrast, the BI (two-way repeated-measures ANOVA; CCh 30′ vs CCh 90′: q= 5.37, 
p=0.003; CCh 30′ vs CCh 120′: q= 8.568, p<0.001) (Figure 4F2), STTCS (two-way 
repeated-measures ANOVA; CCh 30′ vs CCh 60′: q=5.03, p=0.007; CCh 30′ vs CCh 90′: 
q= 5.934, p=0.001; CCh 30′ vs CCh 120′: q= 6.501, p<0.001) (Figure 4F3), BD (two-way 
repeated-measures ANOVA; CCh 30′ vs CCh 90′: q= 5.544, p=0.002; CCh 30′ vs CCh 
120′: q= 5.093, p=0.006) (Figure 4F4), Cpeak (Figure 4F5) (two-way repeated-measures 
ANOVA; CCh 30′ vs CCh 90′: q= 4.86, p=0.01; CCh 30′ vs CCh 120′: q= 5.008, p=0.007) 
and latency ratio (Figure 4 F6) (two-way repeated-measures ANOVA; CCh 30′ vs CCh 
90′: q= 4.607, p=0.016; CCh 30′ vs CCh 120′: q= 4.244, p=0.032) showed a statistically 
significant difference between the time point of 30 minutes and the subsequent time 
points of 90 and 120 minutes by CCh treatment. Indeed, in contrast to PWScrm+/p+ 
cultures, the above parameters showed a statistically significant difference with respect 
to the basal conditions starting 90 minutes after the administration of the drug (Figure 4 
F2- F6). 
When we compared the behaviour of PWScrm+/p+ and PWScrm+/p-, we observed a higher 
increase in the IBR values for PWScrm+/p+ than for PWScrm+/p- in the first hour by the CCh 
administration (Figure 5 F1) (two-way repeated measure ANOVA; CCh 30′: q= 3.767, 
p=0.013; CCh 60′: q= 2.986, p=0.045). At the same time, the BI ratio (Figure 4 F2) (two-
way repeated-measures ANOVA; CCh 60′: q= 3.37, p=0.02) and the Cpeak ratio (Figure 4 
F5) (two-way repeated-measures ANOVA; CCh 60′: q= 3.10, p=0.03) showed lower 
values for PWScrm+/p+ than for PWScrm+/p- after one hour of treatment. Instead, at the 
same time point, the BD ratio revealed higher values for PWScrm+/p+ than for PWScrm+/p- 
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(Figure 4 F4). Therefore, paternal Snord116 deletion causes alterations in the 
synchronization level of activity and a delayed response to CCh treatment. All the 
statistical details from the multiple pairwise comparisons are available in Table S4. 
 
Paternal Snord116 deletion alters the expression of immediate early genes (IEGs) 
in vivo and in vitro 
We explored the impact of Snord116 on the expression of selected IEGs in the cortex, as 
they represent an important target of both neuronal responses and sleep homeostasis. In 
the in vivo experiment, IEG expression was investigated in the FC and PC of adult mice 
(15-18 weeks old) sacrificed at ZT6 and 1 h after 6 h of SD. We observed that at ZT6, 
which constitutes the baseline condition, Bdnf expression was significantly reduced in 
the PWScrm+/p- mice compared to the control (PWScrm+/p+ 1 ± 0.12 vs PWScrm+/p+ 0.46 ± 
0.07, t(8)= 3.73, p=0.005; Figure S4A) in the PC. This increase in the Bdnf level was also 
observed in the PC of mutant mice (PWScrm+/p+ 1 ± 0.12 vs PWScrm+/p+ 0.62 ± 0.06, t(8)= 
2.68, p=0.02; Figure S4A). Moreover, in the PC, a significant reduction in Cfos 
(PWScrm+/p+ 1 ± 0.37 vs PWScrm+/p+ 0.09 ± 0.03, t(8)= 2.38, p=0.04; Figure S4A) and Arc 
(PWScrm+/p+ 1 ± 0.19 vs PWScrm+/p+ 0.37 ± 0.13, t(8)= 2.64, p=0.02; Figure S4A) genes 
was also observed. We noticed that, 1 h after 6 h of SD, the expression levels of all 
investigated IEGs were significantly reduced in the mutant mice compared to control 
mice (Figure 5; see Table S2 for statistical analysis). Conversely, the expression levels 
of all investigated IEGs were, as expected, significantly increased compared to the 
baseline value (ZT6, non-SD mice) in the PWScrm+/p+ mice (Hinard et al., 2012) (Figure 
5; see Table S3 for statistical analysis). The same scenario was observed for the 
expression of IEGs in the PC of the mutant mice (Figure S4A; see Table S3 for statistical 
analysis). 
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Subsequently, the alteration in cortical IEG expression observed in living PWScrm+/p- 
mice 1 h after SD was investigated to determine whether it is also reflected in the 
embryonic cortical neurons. For the in vitro analyses, cortical cultures were stimulated 
with 20 µM of CCh, and RNA was extracted 1 h later, which resembled the in vivo SD 
condition. Conversely, the ZT6 treatment in the in vivo experiment mirrors the cell culture 
stimulated with water (baseline). In primary cell cultures at baseline, the only IEG whose 
expression was significantly different between the two genotypes was Per2. In this 
condition, Per2 was found to be significantly higher in the PWScrm+/p- cultures than in the 
control cultures (PWScrm+/p+ 1 ± 0.31 vs PWScrm+/p+ 19± 2.6, t(8)= 7.01, p=0.0001; Figure 
S4B). It was also observed that, 1 h after CCh treatment, cells displayed the same 
alterations in IEG expression that were observed in the in vivo experiment. Specifically, it 
was observed that all IEG expression levels were significantly lower in the PWScrm+/p- 
mice than in the control mice (Figure 5; see Table S4 for statistical analysis). In contrast, 
PWScrm+/p+ mice showed significantly increased IEG expression after CCh treatments, 
as observed in the in vitro experiments (Figure 5; see Table S4 for statistical analysis). 
Interestingly, only Bdnf, which is not an IEG but is involved in the plasticity mechanisms, 
did not undergo a change in expression in cultured cortical neurons 1 h after CCh 
(Figure 5; see Table S4 for statistical analysis), while in living mice, the expression of this 
gene was significantly altered before and after SD. 
Overall, these in vivo and in vitro results show that IEG expression in the cortex is 
significantly affected by the loss of the Snord116 gene. Additionally, it was observed 
herein that the wake-like (CCh treatment vs SD mice) and sleep-like states (water 
treatment vs ZT6 mice) in vitro underwent changes in gene expression that resembled 
those in the cerebral cortex of living animals. 
 
Discussion  
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The results of this study confirm that the Snord116 gene significantly affects REM sleep 
occurrence and its regulation. Sleep spindle properties were found to be altered in the 
PWScrm+/p- mice, while their numbers were unchanged between the two genotypes, 
suggesting dysfunctions in the cortex where sleep spindles are amplified and not in the 
thalamus where they are generated. Moreover, we also described a previously 
unreported form of intrinsic cortex dysfunction observed in primary cortical neurons 
obtained from PWScrm+/p- mice, reinforcing our results obtained on sleep spindles. Next, 
the electrophysiological and molecular changes that we observed in primary cortical 
neurons resemble the same sleep phenotypes and transcriptional changes observed in 
living mice.  
Mice carrying a paternal deletion of the Snord116 gene display REM sleep 
dysregulation. The increase in REM sleep is pronounced during the dark period, when 
mice are most active, and may resemble the EDS observed in humans PWS 
(Camfferman et al., 2008). Since it has already been reported that REM sleep is 
precisely regulated in terms of its duration, while NREM is substantially regulated in 
terms of intensity (Amici et al., 2008; Borbely & Achermann, 1999), we decided to 
analyse the succession of REM sleep episodes and the period of time intervening 
between the end of one REM sleep episode and the beginning of the next (REM sleep 
interval, RSI). RSI follows a bimodal distribution characterized by short and long periods. 
The presence of a bimodal distribution has already been described (Amici, Zamboni, 
Perez, Jones, & Parmeggiani, 1998) in many species, such as rats (Amici et al., 1994), 
cats (Ursin, 1970) and humans (Merica & Gaillard, 1991), but, at the best of our 
knowledge, no data are yet available on the RSI distribution in mice. For the first time, 
our data reveal a bimodal RSI distribution in mice, with the minimum frequency at 55 
sec, while in rats, the minimum between the two peaks has been identified at 3 min 
(Amici et al., 1998). A bimodal distribution of RSI was observed in both genotypes of 
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mice. However, mutant mice showed a significant increase in short RSI. Short RSI has 
been described as an indicator of the capacity to produce REM sleep in accordance to 
the homeostatic drive under favourable ambient conditions and associated with the 
capacity to produce REM sleep proportionally to the homeostatic drive under favourable 
ambient conditions (Amici et al., 1998; Zamboni, Perez, Amici, Jones, & Parmeggiani, 
1999). Indeed, the amount of REM sleep with short RSIs has been shown: i) to be 
increased during a REM sleep rebound in proportion to the degree of previous REM 
deprivation induced by low ambient temperature (Zamboni et al., 2001); ii) to be 
depressed when animals are kept under an uncomfortable ambient condition, such as 
during the exposure to a low Ta (Amici et al., 1998), and concomitantly with a reduced 
capacity of cAMP accumulation at hypothalamic-preoptic level (Jones et al., 2008; 
Zamboni et al., 2004). This observation may reflect a strengthened drive for REM sleep 
and/or a distorted and more favourable perception of the ambient conditions, in terms of 
the thermal comfort, in the mutant mice. Therefore, since sleep propensity also affects 
the NREM-REM cycle, we also assessed the number of these cycles over the 24 h of the 
BL in both genotypes of mice. As expected, mutant mice presented a significant increase 
in the NREM-REM cycle (approximately 2-5 minutes) (Toth & Bhargava, 2013) 
compared to the control group, suggesting, once again, that the mutant mice have a 
strong tendency to fall asleep easily. Overall, these data imply that the loss of Snord116 
significantly compromised sleep microstructure, mainly affecting REM sleep.  
We found that PWScrm+/p- mice showed alterations in REM sleep without affecting NREM 
sleep. An exception, however, was found in the sleep spindles, hallmarks of NREM sleep 
that reflect the activity of complementary thalamocortical circuits. The thalamic reticular 
nucleus (TRN) is the spindle pacemaker, and TRN/thalamus circuits can generate 
spindles in isolation, although cortical inputs may contribute by initiating or amplifying 
spindle oscillations (Ferrarelli & Tononi, 2017; Fuentealba & Steriade, 2005). Here, we 
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show that the duration, amplitude and frequency of sleep spindles are significantly 
altered in PWScrm+/p- mice, while their numbers are unchanged between the two 
genotypes. This data suggests that TRN/thalamus circuits or in corticothalamic afferents 
to these intra-thalamic circuits may probably not affected in the mutant mice, while, an 
impairment of cortical amplification may explain the alterations of sleep spindles 
properties. Since it has been shown that sleep spindles facilitate neuroplasticity and 
support learning, memory consolidation, and intellectual performance (Gruber & Wise, 
2016), and since sleep spindle alterations have been documented in children with 
neurodevelopmental disorders (Burnett et al., 2017; Gruber & Wise, 2016), we speculate 
that the neurodevelopmental and cognitive alterations observed in these mice (Adhikari 
et al., 2018) may also arise from altered thalamocortical input. Thus, we believe that 
sleep spindle alterations may either reflect the severity of the underlying disorder or 
directly exacerbate the severity of impairments. Evidence also indicates that alterations 
in sleep spindle properties have a very early association with an increased risk of 
cognitive impairment (Taillard et al., 2019); our results imply that sleep spindles may also 
represent reliable sleep EEG biomarkers associated with PWS disorder, although a 
better characterization of these findings in PWS subjects is needed. 
Additionally, we observed that PWScrm+/p- mice have dysregulated norepinephrine levels 
in the CSF collected at the beginning of the dark period. Norepinephrine is a 
neurotransmitter important for maintaining normal sleep states, and dysregulated 
norepinephrine signalling is responsible for cataplexy attacks, which, together with 
narcolepsy, represent common features of PWS (Weselake et al., 2014). Thus, the 
activity of norepinephrine neurons in the locus coeruleus is important in modulating 
cortical activity during NREM sleep (Eschenko, Magri, Panzeri, & Sara, 2012). 
Norepinephrine not only influences general arousal but also affects locomotor activity. 
Indeed, it has been observed that intraventricular infusion of norepinephrine increases 
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motor activity (Geyer, Segal, & Mandell, 1972). Interestingly, we observed that 
norepinephrine was significantly higher in the mutant mice than in the controls, 
suggesting that norepinephrine may also have a role in controlling motor activity in these 
mice. Overall, these data imply that mutant mice may also have a dysregulated 
norepinephrine system. The extent to which norepinephrine alterations may affect the 
sleep-wake cycle and locomotor activity should be further investigated and may have 
therapeutic relevance.  
Our data imply a dysfunction of cortical amplification, manifested by the altered sleep 
spindles properties not affecting their numbers observed in the mutant mice. Based on 
these results, we investigated whether cortical neurons isolated from thalamocortical 
projections showed an altered intrinsic mechanism of sleep comparable to the sleep 
endophenotypes observed in living mice. To address this question, we used an in vitro 
model. Previous studies have demonstrated that embryonic cortical neurons on MEA are 
able to recapitulate some essential features of sleep in a controllable way (I. Colombi et 
al., 2016; Hinard et al., 2012; Saberi-Moghadam, Simi, Setareh, Mikhail, & Tafti, 2018). 
Here, we treated cortical cultures with CCh to change the synchronized default sleep-like 
state, characterized by slow-wave oscillations typical of NREM sleep, into a theta-
predominant state, which is typical of REM sleep. Because of this EEG feature of REM, 
the shorthand definition of REM sleep is a highly activated brain in a paralysed body 
(O'Malley & Datta, 2013). The LFP analysis of MEA cortical neurons revealed 
abnormalities in the theta waves in the PWScrm+/p- neurons similar to those observed in 
living mice. CCh administration caused evident desynchronization of the activity of both 
genotypes, but mutant cultures showed different response profiles after CCh treatment 
compared to control cultures. In particular, PWScrm+/p- cultures displayed less reactivity in 
response to the treatment, especially during the first hour. Overall, these results 
suggested that PWS cultures displayed alterations in neuronal activity patterns during 
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spontaneous activity and when external stimulation was applied. Additionally, the 
analysis of the MEA frequency range revealed aberrant neuronal network activity 
patterns. In particular, PWScrm+/p- cultures displayed less synchronized activity than 
control cultures did, as indicated by their lower BI and STTCs. Moreover, the analysis of 
the cross-correlation during the basal period showed shorter latencies for PWScrm+/p+ 
cultures than for PWScrm+/p- cultures. Taken together, these data imply that Snord116 
may either directly influence the neuronal synchronization of cortical neurons or affect it 
indirectly via norepinephrine, which we found to be altered in our study in living mice. 
Indeed, norepinephrine is a neurotransmitter that decreases network synchrony both in 
vivo (Bergles, Doze, Madison, & Smith, 1996; Colonnese et al., 2010) and in vitro 
(Bergles et al., 1996), consistent with our results, in which PWScrm+/p- cultures showed 
an increased level of this neurotransmitter that may be responsible for the increased 
desynchronization level of activity in the MEA recording. 
Finally, we also assessed the expression of IEGs in both in vitro and in vivo models, and 
we observed that our in vitro model exactly recapitulates the transcriptional alteration 
observed in living mice. This finding also suggests that cortical cultures coupled to MEA 
represent a promising tool to identify novel therapeutic targets, such as sleep feature 
alterations and network synchronization defects. Moreover, these data suggest, in 
agreement with a recent publication (Coulson et al., 2018), that the Snord116 gene 
affects the transcriptional profiles of circadian genes in the cortex (Per2 and Bmal1), 
which are involved in development outside the suprachiasmatic nucleus and contribute 
to brain plasticity (Kobayashi, Ye, & Hensch, 2015). Indeed, we also found that the 
PWScrm+/p- mice had low levels of Bdnf mRNA, which is extremely important in the 
regulation of synapses and the plasticity process. This latter evidence may pave the way 
for new interventional approaches for PWS by using TrkB agonists or by using 
compounds that increase the BDNF level (Habtemariam, 2018). 
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Overall, our results suggest that Snord116 is important in controlling REM sleep. 
Additionally, here we provide the first evidence supporting the role of Snord116 in 
regulating cortical neuronal activity, opening avenues for new interventions in PWS. The 
dysregulation of sleep spindles in our mutant mice raises the possibility that this 
phenomenon can be a clinically useful marker to assess PWS symptoms in humans. 
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Paternal Snord116 deletion impacts REM sleep and NREM sleep spindles:   
A) Schematic representation of EEG/EMG implantation to record the sleep-wake cycle 
and the recorded sleep architecture. With this system is possible to discriminate sleep-
wake changes based on the frequency of EEG and the amplitude of the EMG signals. B) 
The percentage of time spent in in REM sleep during the 12 h light and dark period for 
PWScrm+/p- mice (red) versus controls (black). Values are the 12 h means ± SEM. C) On 
the top, schematic representation of the criteria for the recognition of short-RSI and long-
RSI. On the middle average frequency distribution of the duration of the interval from the 
end of one REM sleep episode to the beginning of the next REM sleep episode (REM 
sleep interval, RSI) recorded over the 24 of the sleep-wake cycles in PWScrm+/p+ (n= 10 
in black) and PWScrm+/p- mice (n= 10 in red). The frequency class which was taken as 
the boundary separating short and long-interval populations (minimum) is at 55-sec. 
Right, average value of the occurrence of the short and long-RSI for each genotype, 
values are expressed as mean ± SEM. On the bottom, histograms of sleep cycle length 
during the 24h of the sleep-wake cycle in PWScrm+/p+ (n= 10 in black) and PWScrm+/p- 
mice (n= 10 in red). Sleep cycles are plotted for 3-hour bins. Only data up to 30 min are 
shown. Four combinations of criteria (see Method section). Cycles containing wake 
sequences >64 s were discarded from the analysis. On the right the average value of the 
number of the cycle length around 2-5 minutes in both genotypes of mice. D1) 
Schematic representation of experimental design to record sleep spindles properties.  
Sleep spindles were recorded at different time point according to the circadian and 
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homeostatic sleep control. At the baseline sleep spindles were recorded at two time 
points (B1 and B2) for 2h between the shift from the light and dark period and vice versa, 
indicated by a green square. Next, sleep spindles were recorded over the first hour of the 
rebound period (RB1) following 6h of total-sleep deprivation (SD) and in other two-time 
points over the 18h of recovery period (RB2 and RB3). D2) Schematic representation of 
the spindles signal; E1) The number of the spindles estimated over the 24h of the sleep-
wake cycles in both genotypes, PWScrm+/p+ (n= 10 in black) and PWScrm+/p- mice (n= 
10 in red). E2) Sleep spindles properties: duration between 0.4-2 s, central frequency, 
peak-to-peak amplitude, number of cycles between 5-30 and symmetry. Values are 




Paternal Snord116 deletion increases physical activity and norepinephrine levels. 
A) On the left, telemetry measurements of daily activity in home cages monitored 24-
hours per day in PWScrm+/p+ (n= 10 in black) and PWScrm+/p- mice (n= 10 in red). On 
the right the spontaneous physical activity averaged during the 12 h light and dark 
period. Values are the 12 h means ± SEM. B) Levels of neurotransmitters (Glycine, 
glutamate, norepinephrine, histamine and GABA) assessed in the CSF of PWScrm+/p+ 
(n= 10 in black) and PWScrm+/p- mice (n= 10 in red). Mice were sacrificed at the 
beginning of the dark period. Values are expressed as mean ± SEM. *p < 0.05; **p < 
0.01; ***p < 0.001 
 
 
Figure 3.  
LFP analysis of PWScr m+/p- and PWScr m+/p+ cultures. A) Experimental protocol 
adopted for the experiments. We recorded two hours of spontaneous phase followed by 
2 hours of CCh administration. B) (Left) Power spectral density of basal segments for 
PWScr m+/p- and PWScr m+/p+ cultures. We computed the power for each set of bands 
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delta (1-4 Hz), theta (5-9 Hz) and beta (9-13 Hz). We did not find any differences during 
the basal phase. (Center) Power spectral density of PWScr m+/p+ cultures under baseline 
conditions (grey line) and during CCh application (black line). CCh caused suppression 
of all the low waves considered. (Left panel) Power spectral density of PWScr m+/p- 
cultures under baseline conditions (light red line) and during CCh application (red line). 
C) Delta power following CCh administration. We normalized the power in each band 
with respect to the basal value (indicated by the dashed line). After dividing the entire 
recording into 30-minute intervals, we did not find a significant difference between 
PWScr m+/p- and PWScr m+/p+ cultures: CCh administration caused a significantly 
decrease of the delta power for both genotype. C1) Theta power following CCh 
administration. We normalized the power in each band with respect to the basal value 
(indicated by the dashed line). After dividing the entire recording into 30-minute intervals, 
we found a significant difference between PWScr m+/p- and PWScr m+/p+ cultures after 1 
hour of treatment. The theta power of the PWScr m+/p+ cultures decreased by 60%, 
whereas that of the PWScr m+/p- cultures decreased by 30%. C2) Beta power following 
CCh administration. We normalized the power with respect to the basal value (indicated 
by the dashed line). After dividing the entire recording into 30-minute intervals, we did 
not find a significant difference between PWScr m+/p+ and PWScr m+/p-. All data are 
presented as the mean +/- SEM. Statistical analysis was performed using Tukey’s post 
hoc test following two-way repeated-measures ANOVA (*p<0.05 indicated statistical 
difference between genotype in the different time- points; º p <0.05 indicated statistical 
difference within the same genotype during Cch administration with respect to the basal 
condition). 
 
Figure 4  
MEA analysis of PWScr m+/p+ and PWScr m+/p- cortical cultures. A) Experimental 
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protocol adopted for the experiments. The 2 hours of basal recording used in the 
analysis are highlighted. B) 150-s raster plots of cortical cultures at DIV 18 during basal 
phase for PWScr m+/p+ and PWScr m+/p-cultures. C) Comparison of MFR in PWScr m+/p+ 
(grey box, N=6) and PWScr m+/p- (light red box, n = 9) cultures during basal phase C1) 
Comparison of BI in PWScr m+/p+ (grey box plot , n = 6) and PWScr m+/p-(light red box, n = 
9) cultures during basal phase. C2) Comparison of STTC values in PWScr m+/p+ (grey 
box plot , n = 6) and PWS (light red box, n = 9) cultures during basal phase. C3) 
Comparison of The top 100 C peak values calculated on burst events in PWScr m+/p+ 
(grey box plot, n = 6) and PWScr m+/p- (light red box, n = 9) cultures during basal phase. 
C4) Comparison of The top 100 Latency value calculated on burst events in PWScr m+/p+ 
(grey box plot, n = 6) and PWScr m+/p- (light red box, n = 9) cultures during basal phase. 
D) Experimental protocol adopted for the experiments. The 2 hours of CCh recording 
used in the analysis are highlighted. E) 150-s raster plots of cortical cultures at DIV 18 
during basal and CCh administration for PWScr m+/p+ and PWScr m+/p-cultures F) 
Comparison of 30-minute time point of MFR in PWScr m+/p+ (black columns, n = 6) and 
PWScr m+/p- (red columns, n = 9) cultures following CCh administration. F1) Comparison 
of 30-minute time point of IBR in PWScr m+/p+ (black columns, n = 6) and PWScr m+/p- (red 
columns, n = 9) cultures following CCh administration. F2) Comparison of BI in PWScr 
m+/p+ (black columns, n = 6) and PWScr m+/p- (red columns, n = 9) cultures following CCh 
administration. F3) Comparison of the top 100 STTC values obtained for PWScr m+/p+ 
(black columns, n 6) and PWScr m+/p- (red columns, n = 9) cultures following CCh 
administration. F4) Comparison of BD in PWScr m+/p+ (black column, n = 6) and PWScr 
m+/p- (red column, n = 9) cultures following CCh administration. F5) Cross-correlation 
analysis of burst events. Bar plot of the 100 highest Cpeak values at each 30-minute 
time point. F6) Bar plot of the corresponding peak latency values (Lpeak) of the 
preselected 100 highest Cpeak values. In each box plot (C C4), the small square 
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indicates the mean, the central line indicates the median, and the box limits indicate the 
25th and 75th percentiles. All data are presented as the mean +/- SEM. Statistical 
analysis was performed using Tukey’s post hoc test following two-way repeated-
measures ANOVA (*p < 0.05 indicated statistical difference among the different time 
points treatment (i.e. CCh 60’ and CCh 120’) within the same genotype,º p < 0.05 
indicated statistical difference within the same genotype during Cch administration with 
respect to the basal condition). 
 
Figure 5 
Paternal Snord116 deletion alters the immediate early genes (IEG) in-vivo and in-
vitro. A) IEG gene expression analysis was performed in PWScrm+/p+ (n= 10 in black) 
and PWScrm+/p- mice (n= 10 in red). Mice were sacrificed after 6 hours of sleep 
deprivation and 1 hour of rebound. Values expressed are relative to wildtype control 
average ± SEM. Green line show the baseline level. **p < 0.01; ***p < 0.001. B) IEG 
gene expression analysis was performed in embryonic cortical neurons obtained from 
PWScrm+/p+  (n= 5 in black) and PWScrm+/p- mice (n= 5 in red). Cells were collected after 1 
hour of CCh treatment. p < 0.05; **p < 0.01; ***p < 0.001. IEG investigated: Fos Proto-
Oncogene, AP-1 Transcription Factor Subunit (C-fos); Brain-derived neurotrophic factor 
(Bdnf); Activity Regulated Cytoskeleton Associated Protein (Arc); D-Box Binding PAR 
BZIP Transcription Factor (Dbp); Homer Scaffold Protein 1 (Homer1a); Brain and Muscle 
ARNT-Like 1 (Bmal1 also named as Aryl hydrocarbon receptor nuclear translocator-like 
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